DNAJC25 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.43689570931383E-15 |
Normal-vs-Stage2 |
5.030600E-04 |
Normal-vs-Stage3 |
2.49311682409825E-12 |
Normal-vs-Stage4 |
1.7954526754238E-12 |
Stage1-vs-Stage2 |
7.623200E-01 |
Stage1-vs-Stage3 |
4.742100E-02 |
Stage1-vs-Stage4 |
7.441400E-03 |
Stage2-vs-Stage3 |
1.371640E-01 |
Stage2-vs-Stage4 |
8.416200E-02 |
Stage3-vs-Stage4 |
7.460800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
6.2732996575221E-10 |
Normal-vs-Asian |
2.50449999994462E-06 |
Caucasian-vs-AfricanAmerican |
5.079000E-01 |
Caucasian-vs-Asian |
5.588200E-01 |
AfricanAmerican-vs-Asian |
2.748800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.27010002515249E-09 |
Male-vs-Female |
9.75989999999483E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.89749999999611E-05 |
Normal-vs-Age(41-60Yrs) |
5.88418203051333E-15 |
Normal-vs-Age(61-80Yrs) |
3.33066907387547E-16 |
Normal-vs-Age(81-100Yrs) |
1.92699999956858E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.160000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.042200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.092000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.619600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.427200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.548200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.95638999999082E-05 |
Normal-vs-Grade 2 |
7.03680003155682E-10 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.6269208202857E-12 |
Grade 1-vs-Grade 2 |
5.599400E-01 |
Grade 1-vs-Grade 3 |
4.769000E-01 |
Grade 1-vs-Grade 4 |
1.685970E-01 |
Grade 2-vs-Grade 3 |
7.902600E-03 |
Grade 2-vs-Grade 4 |
6.781400E-04 |
Grade 3-vs-Grade 4 |
8.199800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.43620001949552E-09 |
Normal-vs-ccB subtype |
5.55111512312578E-16 |
ccA subtype-vs-ccB subtype |
8.240300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.85662596408065E-12 |
Normal-vs-N1 |
1.416150E-03 |
N0-vs-N1 |
2.657800E-01 |
|
|